Morphic Therapeutic (Series A)

Funding Details
Awarder
Inbox
Date Award
June 30, 2016
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$51,500,000

Company Info
Founding Year
2015
Founders
Polaris Partners, T.A. Springer, Schrödinger, Inc., ShangPharma Investment Group
Company Description
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
Market
Oral integrin therapies
Location
Waltham, MA, USA
Coinvestors
AbbVie Biotech Ventures, Omega Funds, Pfizer Venture Investments, Polaris Partners, Schrodinger, Inc, ShangPharma Investment Group, SR One, TA Springer

Links